Special Supplement for Njbiz

SPECIAL SUPPLEMENT FOR NJBIZ

CANCER CARE 2020 Valley’s Breast Cancer Care Team: Skilled, innovative, personalized care

Accredited by the National Accreditation Program for Breast Centers, the highest level of recognition.

Chad DeYoung, M.D. Moira Christoudias, M.D. Thomas Rakowski, M.D. Eleonora Teplinsky, M.D. Scott DeGregorio, M.D. Laura Klein, M.D. Michael Wesson, M.D. Radiation Oncologist Breast Surgeon Medical Oncologist Medical Oncologist Radiologist Breast Surgeon Radiation Oncologist

Proven. Innovative. Here.

Valley Health System’s team of breast cancer specialists is elevating cancer care in our region.

Dedicated to achieving the best possible results, these doctors collaborate on innovative treatments and techniques — including oncoplastic and plastic surgery for the best possible cosmetic outcomes — to ensure each woman not only receives the care and treatment she needs, but is also cared for as a whole person. And through Valley’s partnership with the Mount Sinai Health System for cancer care, these doctors offer women access to innovative research and clinical trials. If you are facing a breast cancer diagnosis, this is the team to choose.

For more information about Valley’s Breast Cancer Team and the treatments they offer, please visit ValleyHealth.com/BreastCancer or call -6- .

20-VHS-0524 Breast Care Team_NJBIZ Cancer Care Flyer_10.125 x 13.5_v1-0.indd 1 2/4/20 4:42 PM TABLE OF CONTENTS

Mailing Address A holistic approach to cancer 220 Davidson Ave., Suite 122, NJ hospitals balance technology with a human touch 6C Somerset, NJ 08873 www.njbiz.com • (732) 246-7677 NJ hospitals are leaders in cancer care PUBLISHER Ken Kiczales Dedication, innovation lead to quality results 10C GENERAL MANAGER AnnMarie Karczmit Rutgers Cancer Institute of New Jersey ADVERTISING unveils plans for new Cancer Pavilion 12C ACCOUNT EXECUTIVE Susan Alexander EDITORIAL John Theurer Cancer Center forges link with ProCure 14C CONTRIBUTING WRITERS Martin Daks Anthony Vecchione Holy Name receives grant to support women PRODUCTION SPECIAL PROJECTS DESIGNER with gynecologic cancers Wendy Martin Peer program to connect patients with survivors from AD DESIGNER diagnosis through treatment 16C Abigail Wilhelm

Published by Bridgetower Media Decline in cancer mortality due in part to investment in research 16C

Cancer Care 2020 | 3C National leaders in Cancer Care

THE LEFCOURT FAMILY CANCER TREATMENT AND WELLNESS CENTER

350 Engle Street | Englewood, NJ 07631 | For referrals and new patient appointments, call 201-608-2266. All of us for all of you.

Find a psician 8-2-22 or A holistic approach to cancer NJ hospitals balance technology with a human touch

By Martin Daks alyzed 24/7, 365 days a year so trends can be identified sooner.” s part of their commitment to providing top level health care, lead- In addition to efficiently and accurately re- ing-edge hospitals and networks viewing pathology reports, the AI system can Acontinue to research new solutions electronically send copies of the analyses to ap- for cancer and other patients. To some degree that propriate members of the care team, including involves a balancing act, as noted by a research physicians, appointment-scheduling staff, and paper on the National Institutes of Health web- social workers — who may coordinate insur- site which notes that patients’ experience “should ance, home-assistance and other activities — in be valued as much as clinical effectiveness” and addition to a patient registry team that collects “services should be tailored to meet their different uniform data so specific diseases or conditions types of needs.” Institutions in New Jersey appear can be studied for large populations. to have taken that message to heart. “This AI-enabled initiative supplements, but The medical professionals at Holy Name does not replace, the multidisciplinary human Medical Center’s Patricia Lynch Cancer Center component,” Tubb said. “Doctors still speak in Teaneck, for example, are helping cancer pa- with patients, nurses and others, because more tients to lead better lives, while simultaneously conversations lead to better outcomes.” eliminating some stereotypes. Inspira is also working to improve the treat- Shattering a myth ment experience with virtual reality headsets “Some people think that clinical oncology that offer cancer patients the option of accessing trials like the ones we’re currently administer- an immersive VR experience, from the serene ing are only surroundings like bird watching, silent medita- available at tion, or small-space yoga, to the thrill of a NA- large can- SCAR race or a roller coaster. cer centers, “Hospital patients receiving infusion therapy but that’s a for example — which can be a lengthy treatment myth and — have the option of utilizing the VR headsets we’re help- to enhance their comfort,” explained Tubb. “It ing to dispel also boosts their sense of control, since they can it,” noted Dr. Sharyn Lew- Patricia Lynch Cancer Center's Dr. Sharyn Lewin - HOLY NAME MEDICAL CENTER select their own immersive experience.” The health care system also offers real-time in, medical in is the principal investigator and her medical tional and yoga classes, and psycho-social sup- Lewin- HOLY NAME MEDICAL interactive connectivity options that enable CENTER director of partner, gynecologic oncologist Dr. Maria Schi- port — that’s delivered by compassionate team family or other loved ones to conveniently of- gynecologic avone, is sub-investigator of the three studies. members. These and other activities all have a oncology at Holy Name. She trained at Memori- “One of the patients who enrolled in the Mer- positive effect on patient outcomes.” fer support during a doctor-patient encounter by al Sloan Kettering and then served on the faculty ck Keytruda study was originally in tremendous remotely participating from the comfort of their at NewYork-Presbyterian / Columbia Universi- pain, with both of her kidneys blocked,” Lewin Combining high-tech with a own home, office or other location. ty Medical Center for five years, but ultimately recalled. “Today, she’s much better and nearly human touch “How often have patients expressed the wish chose to practice at Holy Name. free of the disease.” Inspira Health is another institution that goes to have an advocate by their side to ask ques- “I wanted to able to closely connect with our the extra mile to enhance patient care and expe- tions during their conversation with a physi- patients and their families, while enabling them Collaboration brings results rience, utiliz- cian?” Tubb noted. “Using a smartphone, iPad to access professionals that offer high-level “We focus on collaborating with various phar- ing high-tech or other mobile device, Inspira Health patients expertise, cutting-edge treatment options, and maceutical and medical device companies in the initiatives can now invite selected individuals to securely unparalleled compassionate care,” said Lew- U.S. and around the world to bring cutting-edge, like artificial link with them in a kind of real-time video con- in, who’s been with the local institution for six safe treatments and technology to our patients,” intelligence ference. It also gives patients the option to selec- years. “For example, we are pleased to field a added Ravit Barkama, M.D., associate vice pres- and virtual tively engage in voice-only mode, or to turn the robust offering of clinical trials for gynecolog- ident of clinical development. “Holy Name’s reality. The app off as desired.” ical and other cancers through our Institute for treatment options match and even surpass those health care Clinical Research at Holy Name.” offered at academic medical centers.” system is These kinds of technological advances, along Holy Name oncologists specialize in specific Holy Name Medical Center is also the first also keeping with initiatives like Inspira Health+ wearables cancers and work with other cancer experts to — which automatically send information to a site in the U.S. to open enrollment for a new Tubb - INSPIRA HEALTH human touch create distinct teams that formulate precise treat- clinical study focused on women with ad- as a central patients’ nurses or physician office through an ment plans for each patient’s type of cancer. This vanced ovarian cancer. The MIRASOL study component, Inspira smartphone app that can monitor chron- customized approach minimizes side effects and assesses a new treatment, mirvetuximab, which according to Erev Tubb, M.D., medical direc- ic illness, stay connected with the care team or improves quality of life while enabling patients is an antibody linked to a chemotherapy drug. tor of the oncology program at Inspira Medical Inspira personal trainer, or track fitness goals to remain close to home. This treatment is designed to target and kill tu- Center Mullica Hill. for a healthy lifestyle — all “make a signifi- Last year, Holy Name Medical Center be- mor cells while sparing healthy cells and reduc- “As part of a network-wide initiative, we’re cant, positive difference in patient comfort and came the first site in the U.S. to open a Merck ing side effects. implementing AI technology at two of our outcomes,” explained Tubb. “These and oth- clinical trial to investigate a combination of the Mirvetuximab has been designated by the South Jersey locations: the leading-edge Can- er innovative approaches in cancer and other anti-PD-1 im- U.S. Food and Drug Administration as an or- cer Center at Inspira Medical Center Mullica care are part of Inspira Health’s integrated, ev- munotherapy phan drug, which speeds up the evaluation Hill, and the Frank and Edith Scarpa Regional idence-based approach that helps each patient medication and development of products that demonstrate Cancer Pavilion at our Inspira Medical Center achieve the best possible outcome.” Keytruda and promise for treatment of diseases with few ther- Vineland,” said Tubb. “One of the challenges With initiatives like these, health care insti- Lenvima to apy options. for pathologists — who analyze tissue sam- tutions across the Garden State are continuing a treat eligible “This designation is important because it’s a ples for diagnostic purposes — is to make sure long tradition of putting patients first. By care- patients with signal to doctors and patients that the drug has that information gathered and reported can be endometrial shown potential in early trials,” said Lewin. analyzed and acted on in a timely fashion, so fully combining cutting-edge technology with cancer, which “It’s rewarding and gratifying to be part of Holy cancer and other issues can be diagnosed early, traditional human touch, these and other hospital typically be- Name because this place is different. Patients and treatments can be developed and deployed systems will remain in the forefront of deliver- Schiavone - HOLY NAME MEDICAL gins in the get personalized care — along with such free as soon as possible. Adding an AI layer means ing compassionate, effective care for individuals CENTER uterus. Lew- services as a cancer support community, nutri- that reams of reports can be electronically an- with cancer and other conditions. • 6C | Cancer Care 2020 Sara Chose She chose to take control. to get ahead of Sara has her cancer. choices...

Fight Cancer Close to Home.

Innovative Reasons to Treat Cancer Right Here

1. Two convenient cancer centers for advanced treatment. The Frank and Edith Scarpa Regional Cancer Pavilion in Vineland and the new Leading-Edge Cancer Center in Mullica Hill oﬀer comprehensive care and support.

2. Team collaboration - physicians who specialize in a cancer type or treatment along with navigators, social workers, dietitians, physical therapists and behavioral health specialists.

3. Commitment to prevention and detection - education, high-risk assessments and screenings. Our high-risk program oﬀers genetic testing and individualized screening plans.

4. State-of-the-art radiation suites oﬀering high-precision radiation therapy.

5. Fellowship trained radiologists performing image guided procedures and using advanced technology including 3D mammo and ambient MRI.

6. Operating rooms for treatment oﬀering technologies that include robotic assisted surgery and wireless breast tumor location.

7. Chemotherapy provided in a patient-centered settings including our progressive new infusion center designed by cancer survivors.

8. Rehabilitation and support services that begin before treatment to target better outcomes.

9. Immunotherapy and personalized medicine with personalized care plans supported by genetic testing and targeted therapies.

10. Clinical trials to make new treatments available as soon as possible.

InspiraHealthNetwork.org/Cancer 1-800-INSPIRA YOUR PARTNERS IN

CANCERTHE PATRICIA LYNCH CANCER CENTER AT HOLY CARE NAME MEDICAL CENTER

ADVANCED CANCER CARE FOR EACH UNIQUE PATIENT

Our multidisciplinary teams integrate their expertise, compassion, and support to provide comprehensive care for each patient. We connect with each person’s medical, physical, and social needs in order to provide a personalized cancer care strategy. This is the best A PASSION FOR TREATING THE WHOLE PERSON “Our cancer specialists have been educated and trained at world-class way to treat this cancer centers, and have chosen to practice here at Holy Name because complex disease. we share a passion for knowing and treating the whole person. Through partnerships with scientific powerhouses, our patients have access to progressive clinical trials that are breaking the boundaries of what is Jean T. Jordan, MPA possible in cancer medicine.” Vice President, Oncology Services Patricia Lynch Cancer Center - Elan Diamond, MD Chief, Medical Oncology | Director, Clinical Research

The Patricia Lynch Cancer Center is accredited by the American College of Surgeons Commission on Cancer, the American College of Radiology, and the American Society of Radiation Oncology. COMPREHENSIVE BREAST CANCER CARE Comprehensive breast cancer services begin at the state-of-the-art Breast Center, where patients can have all their diagnostic services accomplished within one location. The center’s 3D tomosynthesis mammograms are 40% more precise than other technology in finding breast cancer. Holy Name’s breast cancer specialists provide the latest, most effective treatments, Internist Grace Candelario, MD, and a patient at Asian Health Services’ Community Health Festival. including oncoloplastic surgery, radiation

Breast Center Medical Director Joshua Gross, MD, therapy, chemotherapy, hormonal therapy, and SCREENINGS = EARLY DETECTION and Breast Imaging Specialist David Chun, MD. targeted therapies. The Cancer Center collaborates with Holy Name Medical Partners providers and Holy Name medical staff to encourage patients to have routine cancer screenings – including mammograms, Pap smears, colonoscopies, and blood testing for cancer markers – in order to detect cancer at its earliest, most treatable stage. Holy Name’s Center for Healthy Living, Asian Health Services, and Familia y Salud programs regularly provide cancer screenings at Holy Name Medical Center and at community Medical Director of Gynecologic Oncology Sharyn Lewin, MD, sites. Genetic testing and counseling are and Chief of Radiation Oncology Benjamin Rosenbluth, MD. Treatment at the Infusion Center. available to guide patients and family MULTIDISCIPLINARY TEAMS PROVIDE members at risk for cancer. CLINICAL TRIALS LEAD TO PERSONALIZED CARE TREATMENT ADVANCES The Cancer Center’s oncologists practice in multidisci- The Cancer Center conducts plinary teams, collaborating with experts in specialized numerous clinical trials that areas of cancer care to provide patients with personal- investigate new therapies, ized care. This approach provides patients with treatment medical devices, and protocols and services that fight the cancer, minimize side effects, for treatment. improve quality of life, and positively impact survivorship.

THERAPY FOR THE MIND, BODY, AND SPIRIT Gynecologic Oncologist Maria Schiavone, MD. Exercise classes, integrative therapies, support groups, and enriching art activities GYNECOLOGIC CANCER CARE have been shown to enhance physical and A gynecologic cancer or complex benign mental health during the cancer journey. condition of the reproductive system demands The Cancer Support Community offers specialized surgical, medical, and cancer educational workshops, support services, services that are provided by highly experi- wellness classes, creative art classes, and An activity during Cancer Survivorship Day. enced gynecologic oncologists at the Cancer social events. All programs are free and Center. Patients are followed from diagno- open to all patients and families, regard- sis to treatment and then throughout their less of where patients receive lifetime. Treatment options include robotic, their treatment. minimally invasive, and open procedures; fertility-sparing surgery; advanced chemother- Holy Name also partners with Sharsheret, apy, including hyperthermic intraperitoneal which supports women who are at risk for chemotherapy (HIPEC); targeted therapies; or have been diagnosed with breast or radiation therapy; and clinical trials. ovarian cancer and their families.

Learn more about the Patricia Lynch Cancer Center at HolyName.org/PLCancerCenter. For new patients wishing to make an appointment at PLCC, call 201-227-6008, or with a Holy Name physician at HolyName.org or HolyNameMedicalPartners.org. NJ hospitals are leaders in cancer care Dedication, innovation lead to quality results By Martin Daks apeutic radiation. The second and third steps tients thereby improving patient outcomes with involve delivery of radiation vertically and hor- the ability to diagnose earlier and with more ac- hanks to dedicated cancer care and other izontally. “AccuBoost allows patients to see the curacy.” professionals, New Jersey-based health area that is being treated,” Henson added. “Since Using Ion, team members can plan their pro- care networks routinely appear in the the diagnosis of breast cancer is one of the most cedures using a CT scan of patients’ lungs to top rankings of patient-satisfaction and T traumatic for any woman, being able to see treat- create a pre-planned path to the pulmonary nod- treatment-quality surveys. It’s no secret that the in- ment as it is delivered through this new technol- stitutions aren’t afraid of exploring and, as appro- ule. The fiber optic technology provides “un- ogy helps patients be informed and involved in priate, adopting new techniques that improve the precedented stability, accuracy and precision,” health of their patients. their care.” according to the medical center, providing re- The Trinitas Comprehensive Cancer Center al-time vision of the airway throughout the nav- Embracing innovation “has brought significant innovation to the pa- igation process and real-time shape information Trinitas Comprehensive Cancer Center — lo- tients we serve in the Central New Jersey re- throughout the entire biopsy. In addition, Ion’s cated in a 28,000-square-foot, five-story build- gion,” noted Trinitas Regional Medical Center Biopsy Marker enables team members to biopsy ing on the campus of Trinitas Regional Medical President and CEO GaryHoran. “We were the the targeted area, track the number of biopsies Center in Elizabeth — is proud to have accom- first cancer treatment center in New Jersey to and visualize alternative biopsy pathways. plished a number of “firsts” including, some offer Rapid Arc radiotherapy technology, a fast “At Hackensack University Medical Center, years back, being the first cancer treatment fa- and precise form of treatment using advanced we are always looking for novel approaches to cility in New Jersey to offer its breast cancer technology from Varian Medical Systems. Ac- patient care,” said Nabil Rizk, chief, Thoracic Rutgers Cancer Institute researcher. - JOHN O'BOYLE patients AccuBoost radiotherapy technology. cuBoost is another clear example of why Trini- Surgery at Hackensack University Medical Cen- made outstanding scientific contributions to- An image-guided, non-invasive adaptive breast tas is a regional leader in cancer care.” ter. “Ion’s revolutionary robotic platform will ward the national goal of reducing cancer inci- brachytherapy treatment, AccuBoost’s accuracy help our team members evaluate patients more dence and improving the outcomes for cancer and other advances allow early-stage breast can- A different way of looking at quickly by mapping out a path to the pulmonary patients,” added Libutti. “Rutgers Cancer Insti- cer patients who have undergone a lumpectomy things nodule, navigating a precise target, performing tute coordinates basic, clinical and population to retain healthy breast tissue. This makes a sig- Another institution was the first in New Jer- biopsies and receiving real-time information.” research through comprehensive research pro- nificant difference in patient outcomes, accord- sey to offer minimally invasive robotic lung bi- The Ion system will integrate seamlessly into grams comprised of faculty members supported ing to Clarissa Henson, M.D., chair of Radiation opsy procedures. Hackensack Meridian Health Hackensack University Medical Center’s ex- Oncology at Trinitas. Hackensack University Medical Center recently isting technology, he noted. “The technology by peer-reviewed grants and Rutgers Cancer announced that the medical center was the first will help team members treat patients in a more Institute shared resources. Close to 250 Rutgers hospital in the state to implement Ion, described targeted, precise manner. It will also reduce the Cancer Institute faculty members garner more as “a cutting-edge, robotic-assisted technology amount of procedures over the long-term, im- than $100 million annually in federal, state and that will enhance the care of patients with lung proving overall patient outcomes.” philanthropic grant support.” This comprehen- abnormalities, detect lung cancer earlier and im- sive collaboration includes work with investi- prove outcomes.” A local approach gators from the Institute’s research consortium “Hackensack University Medical Center Health care providers like RWJBarnabas partner, Princeton University. is at the forefront of providing leading-edge Health are also all-in when it comes to advanc- Precision medicine for cancer is one of the treatments that enhance patient care,” said Ihor ing patient care. “A cancer diagnosis not only many advanced approaches undertaken by Rut- Dr. Clarissa Henson - TRINITAS Sawczuk, president, Northern Region, and chief impacts the patient, it often impacts the patient’s gers Cancer Institute to deliver the most appro- RUTGERS CANCER INSTITUTE research officer, Hackensack Meridian Health. entire support network,” according to Steven Li- priate treatments based on the characteristics “AccuBoost uses real-time, image-guidance “Utilizing an innovative, new robotic-assisted butti, director of the Rutgers Cancer Institute of of an individual’s cancer, he added, noting that via mammography to localize the treatment,” technology like Ion, our team members will re- New Jersey and senior vice president, oncolo- some of the treatments are offered as part of she explained. “This technology is far superior design the way we care for patients with lung gy services, RWJBarnabas Health. “Having the clinical trials at Rutgers Cancer Institute and to the current standard of care treatment. On abnormalities by doing real-time lung biopsies, best possible therapies close to home makes the are available through RWJBarnabas Health lo- average, only 51 percent of the treatment area diagnosing lung cancer earlier and providing treatment experience — which can involve mul- cations. receives 90 percent of the dose when using the more precise treatment.” tiple modalities and be time intensive — easier Sharing surgical expertise on complex cases current standard of care. With AccuBoost and Ion’s robotic-assisted platform allows for on both the patient and his or her support team.” and other innovative treatment modalities is also image-guidance, targeting is improved and a a minimally invasive biopsy of the lung, he part of the collaboration. “The Laurie Proton more-effective dose of radiation is delivered to noted, while the system’s “precision and flex- Therapy Center at Robert Wood Johnson Uni- the tumor site.” ibility enable opti- versity Hospital New Brunswick – an RWJBarn- By allowing doctors to see the site where mal lung navigation abas Health facility – and Rutgers Cancer Insti- cancer was removed and treat the surrounding and produce more tute represent the only proton therapy program breast tissue area more effectively, AccuBoost accurate biopsies.” in our state to operate under an NCI designa- targets the extent of the disease and specifically Ion will be used for tion,” Libutti explained. “And our bone marrow treats the infected tissues, Henson noted. “In this lung cancer screen- transplant program at both of these locations is way, it identifies areas where cancer might like- ing and early diag- one of only two in the state to offer this critical ly reoccur if left untreated.” nosis by providing Rutgers Cancer Institute level of care.” It’s also more convenient for patients. Uti- more access to small As the state’s only National Cancer Institute In the near future, this leading-edge care will lizing accelerated partial breast irradiation with airways, or hard-to- (NCI)-designated Comprehensive Cancer Cen- be augmented with the addition of a new 12-sto- AccuBoost technology, the radiation portion of Ion reach nodules “that ter, the Rutgers Cancer Institute team of interna- ry, 510,000 square foot cancer pavilion proposed breast-conserving therapy can be delivered in Fiber Optic Technology other technologies tionally recognized physicians and researchers for the campus, “providing access to consolidat- just five to 10 days. “This is both a powerful and are unable to achieve,” as well as for patients is driven by a singular focus and mission: to help ed inpatient and outpatient cancer care, with re- convenient option as it treats only a portion of who are not surgical candidates but need biop- individuals fight cancer, he added. “Through the lated care amenities including access to social the breast to the desired dose and does so on a sies to treat cancers. transformation of laboratory discoveries into work services, wellness programs and more,” very patient-friendly treatment schedule of once- “Hackensack University Medical Center is clinical practice, we target cancer with precision according to Libutti. “This landmark location or twice-a-day treatments for one to two weeks,” committed to delivering the highest quality medicine, immunotherapy and clinical trials will also provide research facilities for ground- Henson explained. “This way, the schedule for care and the best possible patient experience,” and provide the most advanced, comprehensive, breaking discoveries. With New Jersey consis- treatment can be made compatible with the pa- added Mark Sparta, president and chief hospi- and compassionate world-class cancer care to tently ranked in the top 10 for cancer incidence, tients’ work- or home-life schedules.” tal executive, Hackensack University Medical adults and children. This mission is being ac- it is imperative that the residents of our state and The image-guided feature of AccuBoost al- Center and executive vice president of Popula- complished in partnership with RWJBarnabas region have access to such a world-class facility, lows for the visualization of the tumor bed tion Health, Hackensack Meridian Health. “Ion, Health. Rutgers Cancer Institute physicians and which will bring patient care and experience to directly as the breast is immobilized and com- a state-of-the-art technology, demonstrates our scientists work side by side to make sure the the next level.” pressed through mammography, which is im- commitment to high-quality care by providing most sophisticated treatments are delivered to Cancer and other patients win when medical portant since imaging of the lumpectomy cavity our world-class clinical team with the capability our patients quickly and safely,” Libutti said. professionals combine leading-edge technology is the first step in the accurate delivery of ther- of delivering more targeted treatment to our pa- Rutgers Cancer Institute researchers “have with a dose of humanity. • 10C | Cancer Care 2020 TRMC CD NJBiz.qxp_Layout 1 2/11/20 1:49 PM Page 1

THE CONNIE DWYER BREAST CENTER AT TRINITAS

Trinitas Regional Medical Center has partnered with The Connie Dwyer Breast Cancer Foundation to open a new breast center in Connie’s name at Trinitas. The brand new $3.4 million facility offers a highly empathic approach to screening, diagnosis, treatment, community outreach and education to all women, regardless of financial status.

TrinitasRMC.org (908) 994-5984

WE’RE GETTING BETTER, TOGETHER Rutgers Cancer Institute of New Jersey unveils plans for new Cancer Pavilion

RCINJ rendering.-RUTGERS CANCER INSTITUTE OF NEW JERSEY By: Anthony Vecchione said Dr. Steven Libutti, director, Rutgers Cancer into three primary components: Outpatient Care Inpatient Care will include 96 inpatient beds @VECCHIONE_NJBIZ Institute of New Jersey and senior vice presi- (including treatment and clinical components); on three floors, a dedicated floor for surgical and lans for a new cancer pavilion in New dent, oncology services, RWJBarnabas Health. Inpatient Care and Research. procedure rooms (up to 11 total), a central ster- Brunswick were announced in Febru- “This landmark facility will create an environ- Outpatient Care will consist of 84 infusion ile processing area, and inpatient support spaces. ary by the Rutgers Cancer Institute of ment conducive to exceptional patient care and bays, 74 exam rooms, advanced radiology in- Research will include wet lab facilities and PNew Jersey that will result in the con- experience, and provide research facilities for cluding four linear accelerators, diagnostic equipment necessary to support 10 research solidation of services into a single Cancer Pavilion, groundbreaking discoveries – further enhancing equipment including CT, MRI, Mammogram teams (with each research team to be comprised and will allow for the consolidation of key cancer our role as the state’s only National Cancer In- and other equipment with core laboratory and of between four and eight members), clinical tri- services into a single location including laboratory stitute-designated Comprehensive Cancer Cen- pharmacy facilities and outpatient urgent care. al offices and faculty offices.• services, an outpatient clinic, infusion/chemother- ter. Given the large number of people diagnosed apy suite, radiation oncology, imaging, and inter- with cancer each year, we are already behind “This landmark facility will create national radiology. schedule. Cancer can’t wait.” The new Pavilion will be a 12-story structure The new facility will provide for the develop- an environment conducive on Somerset Street, comprised of approximately ment of New Jersey’s only oncology inpatient 510,000 square feet. hospital and will expand service offerings to to exceptional patient care The total project budget is estimated at $750 cancer patients – including the creation of a new million, resulting in 1,000 construction jobs and oncology urgent care center to reduce avoidable and experience, and provide employing approximately 500-600 people ac- and costly ER visits – and will provide access to cording to Chris Paladino, president of DEVCO, multidisciplinary clinics. research facilities for groundbreaking the New Brunswick Development Corp. Paladi- The project includes: discoveries – further enhancing our role as no told NJBIZ that the anticipated groundbreak- • Development of new Cancer Pavilion ing is scheduled for late Fall 2020 with comple- building; tion 36-months later. the state’s only National Cancer Institute- Paladino said that it will be the first com- • Renovations to the existing Cancer prehensive cancer center in the state that will Institute; designated Comprehensive Cancer also have inpatient facilities and inpatient sur- • Bridge connection from the new Cancer Center. Given the large number of people gical facilities. Pavilion to Robert Wood Johnson “With New Jersey consistently ranked in the University Hospital; diagnosed with cancer each year, we are top ten for cancer incidence it is imperative that • Bridge connection from the new Cancer the residents of our state and region have access Pavilion to the existing Cancer Institute. already behind schedule. Cancer can’t wait.” to a world-class inpatient and outpatient cancer care facility such as the new cancer pavilion,” The new Cancer Pavilion is broadly organized — Dr. Steven Libutti 12C | Cancer Care 2020 CS CancerAdRobot 10.75x14 NJBiz.qxp 2/7/20 12:23 PM Page 1

ROBOTIC- ASSISTED CANCER SURGERY

Robotic surgery with a HUMAN TOUCH Robotic surgery for cancer is available almost everywhere. What's not available everywhere are surgeons who not only have expertise and skill in the precision technique, but who combine it with a passion for providing personalized care that extends to the entire patient experience. At CentraState, robotic surgery goes hand in hand with the human touch.

Visit centrastate.com/personal to learn how we give you our personal best.

Troy Sukkarieh, MD Urologic Surgeon Director of Robotic Surgery Your cancer care—it’s personal John Theurer Cancer Center forges link with ProCure ackensack Meridian John Theurer X-ray particles called photons to target tumors, types of cancers as well as some non-cancerous cer Center. “Radiation therapy is undergoing a Cancer Center now offers proton present two problems. First, they radiate all tumors. Each patient’s doctors can help deter- sort of renaissance with these novel radiation beam therapy, the most technolog- tissues in the way of the radiation beam and mine the most appropriate treatment plan. Pro- modalities. Our cancer care team has excep- Hically advanced method to deliver second, after reaching their target – the tumor – ton therapy may be an option for patients with tional expertise and extraordinary tools to help radiation treatments to cancerous tumors available, some photons scatter to nearby tissues, leading these types of cancers: patients make the best decisions for their care.” through a new clinical affiliation with ProCure to greater toxicity. • Prostate cancer Proton therapy can be especially beneficial Proton Therapy Center in Somerset. By contrast, in proton beam therapy, the par- • Brain tumors for children, who can experience more serious With the alliance, Hackensack Meridian pa- ticles called protons enter the body at a low en- • Certain cancers in children short- and long-term side effects from x-ray ra- tients now have access to all available forms of ergy level and release most of their energy upon • Head and neck tumors diation than adults. Since their bodies are still radiation therapy. impact with the tumor, so there is no exit dose, • Skull- based tumors growing, children are more sensitive to healthy “At Hackensack Meridian Health, we’ve long which reduces by over 60 percent the exposure • Tumors near the spine tissue damage caused by x-rays. Clinical stud- provided a wide range of highly precise radia- to radiation of nearby healthy tissues. This is an • Lung tumors ies suggest that proton therapy reduces the risk tion therapy especially important benefit when a tumor is lo- • Esophageal cancers of growth and developmental problems, as well technologies cated near critical organs or structures such as • Breast cancers as secondary tumors. Children receiving cancer to meet our pa- the brain, heart or spinal cord. As proton beam • Lymphomas treatment at the Children’s Cancer Institute at tients’ needs, therapy delivers highly targeted energy (pin- • Testicular cancers Hackensack University Medical Center’s Joseph treatments that point radiation) with less toxicity, higher doses “Being able to offer the most technologically M. Sanzari Children’s Hospital also have access target tumor can be delivered. Proton beam therapy is now advanced method to deliver radiation treatment to proton therapy at ProCure NJ. tissue while recognized as at least as effective as convention- will allow our radiation oncologists to customize Proton therapy is typically offered at free- sparing nearby al radiation therapy with much less toxicity. the best treat- standing centers like ProCure NJ, rather than healthy tissue ProCure NJ was the first to bring proton ment options being incorporated into individual hospitals. as much as therapy to the tri-state region and offers Pencil for our pa- “We’re very fortunate that our patients have Goy - HAUMC possible. The Beam Scanning — the most advanced form of tients at John access to proton therapy right here in New Jer- affiliation with proton therapy — which uses an ultra-narrow Theurer Can- sey, only about an hour from Hackensack,” said ProCure NJ will give our adult and pediatric proton beam that deposits a radiation dose more cer Center,” Dr. Thomas Bauer, clinical medical director, On- patients direct access to every type of radiation precisely within a tumor. PBS allows physicians said Dr. Andre cology, Hackensack Meridian Health. “This is therapy now available for people with cancer,” to precisely paint the tumor with radiation, min- Goy, chairman important when someone is battling cancer, the said HMH Chief Executive Officer Robert Gar- imizing radiation exposure to healthy tissue and and executive treatment for which can be exhausting. Receiv- rett in a statement. reducing the risk of side effects. director, John ing care close to home can offer patients comfort Conventional radiation therapy, which uses Proton therapy is effective for treating certain Garrett-HUMC Theurer Can- and convenience.” • 14C | Cancer Care 2020 FITNESS IS AT KATIE’S CORE TREATING HER CANCER IS AT OURS

As a personal trainer, Katie motivates people for a living. When she was diagnosed with thyroid cancer, she found encouragement with the experts at Hackensack Meridian Health. Here, patients are supported by highly specialized physicians that bring a collective knowledge of the most effective therapies, technology and research. And as part of the most comprehensive health care network in New Jersey, we’re not just at the forefront of cancer, we’re pioneering the possible

LEARN ABOUT PIONEERING THE POSSIBLE Visit HackensackMeridianHealth.org/LearnMore or call to speak to a nurse at 732-776-4240.

A member of the Memorial Sloan Kettering - Hackensack Meridian Health Partnership Jersey Shore University Medical Center | JFK Medical Center | Ocean Medical Center | Raritan Bay Medical Center – Old Bridge Raritan Bay Medical Center – Perth Amboy | Riverview Medical Center | Southern Ocean Medical Center

HMH-2102-Katie-10.125x13.5-NJBiz-20.indd 1 2/13/20 12:49 PM Holy Name receives grant to support women with gynecologic cancers Peer program to connect patients with survivors from diagnosis through treatment By: Anthony Vecchione “We are so thrilled to receive this grant,” said to gaining a deeper understanding of their own hold hands. But it’s these special bonds that can @VECCHIONE_NJBIZ Dr. Sharyn Lewin, director of the division of gy- relationship to their illness. give hope at a very scary time, and that is critical.” oly Name Medical Center said Feb. necologic oncology at the Patricia Lynch Can- Once training is complete, survivor volun- “When you’re faced with any type of cancer, 7 that it received a $25,000 Ovarian cer Center at Holy Name. “This is an incredible teers will be matched with patients based on having someone who can relate to your experi- Cancer Research Alliance(OCRA) opportunity for us to connect our patients with cancer type, age, language and culture, patient ence can be extremely beneficial, both mentally Hgrant to develop and launch Wom- women who understand – on a deeper level – preferences, and other relevant factors. Then, and emotionally, said Lewin. “We see this pro- an-to-Woman, a peer support program for women what they are going through.” they’ll meet one-on-one with their matched pa- gram as a unique way to support and strengthen diagnosed with gynecologic cancer. During program development, survivor vol- tients to listen, discuss concerns, and provide our patients.” The medical center said that the program pairs unteers will receive intensive training focused guidance and support. The Woman-to-Woman program was first gynecologic cancer patients with trained survi- on active listening, communication skills, and “We’re thrilled to be reaching even more wom- established in New York in 2004 and has since vor volunteers who provide one-on-one support how to address cultural differences. They also en with this program,” said Audra Moran, presi- been implemented in more than 40 hospitals and mentoring from the moment of diagnosis will receive an overview of gynecologic cancers dent and chief executive officer of OCRA. “Our and community-based organizations through- through the end of treatment. and the issues associated with them, in addition volunteers listen, share advice, sometimes just out the county. •

Decline in cancer mortality due in part to investment in research By: Anthony Vecchione data (2008-2017), continuing a trend that began tions in mortality accelerated from 3 percent development of targeted immunotherapies that @VECCHIONE_NJBIZ in the early 1990s, and resulting in the 29 per- per year during 2008-2013 to 5 percent per year until recently have sometimes only been avail- cent drop in cancer mortality in that time. during 2013-2017 in men, and from 2 percent to able in clinical trials,” Mehnert told NJBIZ. he cancer death rate declined by 29 per- The drop translates to approximately 2.9 mil- almost 4 percent in women. Mehnert said that there are a lot of advantages cent from 1991 to 2017, including a 2.2 lion fewer cancer deaths than would have oc- However, lung cancer still accounts for almost to participating in clinical research protocols. percent drop from 2016 to 2017 — the curred had mortality rates remained at their peak. one-quarter of all cancer deaths, more than breast, “Research is expensive and can cost money largest single-year drop in cancer mor- T In this day and age a lot of times a clinical prostate, and colorectal cancers combined. and can often only be done at specialized centers tality ever reported, according to Cancer Statistics, trial is the best way folks can get access to a Dr. Janice Mehnert, a medical oncologist at like ours. It drives home the point that histori- 2020, the latest edition of the American Cancer life-saving therapy. the Rutgers Cancer Institute of New Jersey, said cally a lot of folks thought of clinical trials as a Society’s annual report on cancer rates and trends. Lung cancer death rates have dropped by 51 when it comes to dollars spent on research, for last resort but that is really starting to change. In Data from the report reveals that overall can- percent (since 1990) in men and by 26 percent skin cancer, in particular, the data from the study this day and age a lot of times a clinical trial is cer death rates dropped by an average of 1.5 per- (since 2002) in women, with the most rapid shows a return on investment. the best way folks can get access to a life-saving cent per year during the most recent decade of progress in recent years. For example, reduc- “A lot of our advances lately are due to the therapy,” said Mehnert. • 16C | Cancer Care 2020 I’ve got cancer but I also have an expert oncology nurse navigator on my side.

Fighting cancer can feel overwhelming, with so many meetings, decisions, procedures, and questions. Our nurse navigators ensure you don’t have to do it alone. With NCI expertise and compassion, they can walk you

Designated through every step of your treatment process. Comprehensive They demonstrate the high level of care you’ll Cancer Center find, along with our innovative therapies and cutting-edge research, at New Jersey’s only NCI-designated Comprehensive Cancer Center.

Visit rwjbh.org/beatcancer or call 844-CANCERNJ.

Let’s beat cancer together. Accelerating Access to Breakthrough Cancer Therapies Atlantic Health System Cancer Care is dedicated to providing patients with access to the most promising and life-saving trials, research, and innovations in the communities CAR T-Cell Therapy Trial Pioneering Treatment for where they live and work. Cutting-edge initiatives include the following: Atlantic Health System is proudly treating Pancreatic Cancer patients in a new Phase II clinical trial of CAR T-cell “Having worked with hundreds of pancreatic Breakthrough therapy at Morristown Medical Center. cancer patients and dozens of clinical trials, this is truly a time of cautious optimism for people with “A type of immunotherapy for lymphoma known Oncology Accelerator pancreatic cancer, with an explosion of clinical as CAR T-cell therapy has generated a great deal In affiliation with the Translational Genomics trials and new treatments and many more on the of excitement within the medical community Research Institute (TGen) of Phoenix, AZ, horizon,” said Angela Alistar, MD, medical director because it uses a patient’s own immune cells to Atlantic Health System Cancer Care has of GI medical oncology at Morristown Medical attack their cancer,” said Dr. Mohamad Cherry, created the nation’s first Breakthrough Center, Atlantic Health System Cancer Care. medical director of hematology for Atlantic Health Oncology Accelerator, a pioneering research System Cancer Care. “Two types of CAR T therapy and clinical collaboration that offers multiple “I tell pancreatic cancer patients that their best are FDA-approved for certain types of advanced or early and late-phase clinical trials, right here option is to enroll in a clinical trial,” she said. recurrent lymphoma. Other CAR T-cell therapies for in New Jersey. “The Accelerator is designed “Every case of pancreatic cancer is different and non-Hodgkin’s lymphoma, including the one we’re to improve patient access to life-saving responds differently depending on the therapy, testing, are now in clinical trials.” therapies through more rapid deployment the patient and their cancer. It’s a matter of finding the right trial for each person’s diagnosis.” of new research trials and novel payment “We’re excited to achieve this milestone and so mechanisms post-approval,” said Eric far, patients with aggressive B cell lymphomas Whitman, MD, medical director of Atlantic receiving approved CAR T therapies respond Health System Cancer Care. to the treatment almost 80% of the time,” said Dr. Cherry of the therapy, conducted on Clinical trials aren’t just last- an outpatient basis and sponsored by Juno Community Oncology chance options; they often Research Program Therapeutics. provide the best treatment choices. Atlantic Health System Cancer Care is the “We’ve made great progress in treating non- lead affiliate of Atlantic Health Cancer Hodgkin’s lymphoma over the last several years ANGELA ALISTAR, MD Consortium (AHCC), the only New Jersey- and survival rates have increased,” Dr. Cherry Medical Director of GI medical oncology based Community Oncology Research said. “A number of other promising therapies and at Morristown Medical Center, Atlantic Health System Cancer Care Program (NCORP) designated by the National treatment approaches are now also in clinical Cancer Institute (NCI). “Covering 73% of trials, including targeted therapy, chemotherapy, the state’s population, the AHCC NCORP radiation therapy, stem cell transplantation, presents a substantial opportunity to immunotherapy and, very rarely, surgery.” advance scientific understanding of cancer “While newer types of therapy have While the causes of pancreatic cancer remain prevention, screening, control, treatment revolutionized cancer treatment, most unknown, Dr. Alistar confirmed that participation and care delivery research within a large and non-Hodgkin’s lymphoma patients receive in clinical trials can increase patients’ chances diverse population,” said Missak Haigentz, chemotherapy, often as a combination of chemo of living a longer life. “Clinical trials aren’t just MD, medical director of Hematology and drugs or in combination with immunotherapy, last-chance options; they often provide the best Oncology for Atlantic Health System and targeted therapy or radiation therapy,” said treatment choices,” she said, noting that Atlantic principal investigator for AHCC NCORP. Dr. Cherry. “Some of these combinations are Health System Cancer Care is on the pioneering now being further studied in clinical trials to edge of many promising trials. “Together, we can determine the most effective combinations and fight this.” doses, with the fewest side effects.” To learn more about this clinical trial and other clinical trials available at Atlantic Health System, visit atlantichealth.org/research Fighting Melanoma from the Inside Out Advancing Cancer Care Six years ago, Pennsylvania resident John Snyder John soon became one of the first patients and Research for the learned he had melanoma, an aggressive type of in New Jersey to undergo this innovative Tri-State Region skin cancer. By last summer, he was running out treatment at Morristown Medical Center, one of options — and time. of a few sites in the nation to offer this ground- The physician researchers at Atlantic Health breaking treatment. System Cancer Care are leading the fight “Nothing my doctors tried was working,” said against cancer by pioneering nationally and John, 57. “It wasn’t looking good for me.” “Within four weeks of a single treatment, signs internationally recognized phase I to III clinical indicated that it was working well for John,” trials that offer new hope to patients. Atlantic His local physicians then delivered the hopeful Dr. Whitman said. “His cancer isn’t growing Health System Cancer Care Specialty Programs news that researchers three hours away, at or spreading; in fact, his tumors have shrunk and innovative studies investigating the newest the Atlantic Melanoma Center at Morristown almost completely.” cancer treatments include: Medical Center, were testing an experimental therapy for cancer like John’s. According to Dr. Whitman, Morristown Medical › The Atlantic HPV Center, the region’s only Center opened more than 50 clinical trials center dedicated to the treatment of human The new therapy in Morristown, part of a for cancer in the last year. Over the past 20 papillomavirus (HPV)-associated oropharyngeal promising field called “personalized medicine,” years, such trials have helped pave the way to cancers, as well as immunotherapy treatments involves using part of a patient’s own blood to FDA approval for new, exciting treatments for for HPV-associated head and neck cancer. fight cancer and is available through a clinical melanoma and other cancers. trial known as “tumor-infiltrating lymphocyte › The Gerald J. Glasser Brain Tumor Center, one (TIL) therapy.” “Even in late-stage cancer, patients should of only two American Brain Tumor Association seek clinical trials that are appropriate for their designated sites in NJ, is participating in a Designed to identify and replace less-effective specific disease,” Dr. Whitman said. worldwide TOCA-5 immunotherapy trial. white blood cells to attack and kill the patient’s cancer, “this therapy is intended for people like “The future cures for cancer are going to be › The only study site in New Jersey offering John, who have failed all standard forms of totally different than they’ve been in the past, tumor-infiltrating lymphocyte therapy (TIL) treatment and have run out of easy options,” thanks to research and researchers like these,” therapy for melanoma, head and neck cancer shared Eric Whitman, MD, medical director John concluded. “So don’t ever give up hope.” and lung cancer. of Atlantic Health System Cancer Care and principal investigator for that clinical trial. › Internationally recognized phase I research that offers new hope for late-stage pancreatic cancer.

› The internationally recognized Atlantic Melanoma Center, the first in the world to enroll a patient in a Phase IIa trial of a virus-based immunotherapy.

› Among the first centers in the nation to participate in an MD Anderson Cancer Center clinical trial for the early detection of ovarian cancer.

› The only site in New Jersey leading two clinical trials that use novel approaches to target treatment resistance in acute myeloid leukemia (AML) - the fastest growing and most difficult to treat type of leukemia.

Comprehensive Oncology Care Atlantic Health System Cancer Care offers an unparalleled network of cancer specialists and resources for more than 70,500 patients annually through its flagship Carol G. Simon Cancer Center at Morristown and Overlook medical centers, as well as its comprehensive oncology programs at Chilton, Hackettstown and Newton medical centers. With more than 250 cancer specialists and medical professionals, all five hospitals and Atlantic Medical Group have been recognized locally, regionally and nationally for their role in advancing the fight against cancer.

To learn more about Atlantic Health System Cancer Care, visit atlantichealth.org/cancer WE’VE GOT CANCER SURROUNDED

Breakthrough Cancer Care Starts Here

MORRISTOWN | OVERLOOK | CHILTON | NEWTON | HACKETTSTOWN